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Abstract Biphasic calcium phosphate (BCP) bioceramics
have been successfully applied in a broad variety of presenta-
tion forms and with different ratios of hydroxyapatite (HA)
and β-tricalcium phosphate (β-TCP). BCPs have been loaded
with stem cells from different origins for bone tissue engineer-
ing purposes, but evidence of stem cell behavior on different
compositions (various HA/β-TCP ratios) and physical fea-
tures of BCPs is limited. We compared the adhesion, prolifer-
ation, viability and osteogenic potential of human mesenchy-
mal stem cells (MSCs) on granular BCPs with equal HA/β-
TCP ratio of diverse particle sizes and on porous blocks which
had different chemical compositions. In addition, the osteo-
genic differentiation of MSCs was compared to adipose-
derived (ADSC) and dental pulp (DPSC) stem cells, as well
as to pre-osteoblasts on a particulate BCP. MSCs growing on
granular BCPs demonstrated increased number as compared
to MSCs growing on blocks. Cells proliferated to a greater
extent on small granular BCPs, while large granular BCPs
and blocks promoted cell differentiation. Surprisingly, the ex-
pression of genes involved in osteogenesis was upregulated in
MSCs on bioceramics in basal medium which indicates that
BCPs may have osteoinductive potential. This was confirmed
with the upregulation of osteochondrogenic markers, at differ-
ent time points, when stem cells from various tissues were
grown on the BCP. This study demonstrates that BCPs, de-
pending on their physical features and chemical composition,
modulate stem cell behavior, and that stem cells from different
origins are inherently distinct in their gene expression profile
and can be triggered toward osteochondrogenic fate by BCPs.
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Introduction
Successful reconstruction of critical size bone defects requires
bone grafts or graft materials capable of restoring function by
promoting new bone ingrowth and adequate biomechanical
support. Biphasic calcium phosphate bioceramics (BCP) have
been considered optimum bone graft substitutes due to their
proven safety, osteoconductivity, bioactivity, biocompatibility,
unlimited availability and their potential use as a scaffold for
tissue engineering and drug delivery systems (Ohgushi and
Caplan 1999; Le Nihouannen et al. 2007; Saldaña et al.
2009; Cheng et al. 2010; Lobo and Livingston Arinzeh
2010; Schumacher et al. 2010; Wang et al. 2010; Yuan et al.
2010). BCP scaffolds, composed of different ratios of hy-
droxyapatite (HA) and β-tricalcium phosphate (β-TCP), can
have a variety of surface topographies, pore sizes and poros-
ities (Arinzeh et al. 2005; Mastrogiacomo et al. 2006; Fellah
et al. 2010) and have been widely used in several forms, such
as granules or particulates, blocks, cements and custom-made
implants. These biomaterials can also be fabricated as com-
posites with natural and polymeric materials, thus fulfilling a
broad range of clinical demands that include non-loading and
load-bearing sites as well as the reconstruction of major bone
defects (Ohgushi and Caplan 1999; Livingston et al. 2003;
Marcacci et al. 2007; Matsushima et al. 2009; Saldaña et al.
2009; Schumacher et al. 2010; Teixeira et al. 2010; Weir and
Xu 2010; Garrido et al. 2011; Fig. 1).
Biomaterials with different presentation forms have distinct
clinical applications. For instance, granules and cements are
normally used to fill bone cavities that result from bone
cysts and tumors; granules are also used to restore areas
where the need for faster bone formation surpasses the
requirement for higher stability and mechanical strength.
Alternatively, blocks, pre-shaped devices (such as wedges
and cages) and custom-made implants (designed specifically
for each patient) are usually for sites subjected to high loads
and for aesthetic and accurate anatomical reconstruction im-
mediately after the surgical procedure (de Oliveira et al. 2007;
Garrido et al. 2011).
The diversity of tissue response and mechanical properties
achieved in BCP scaffolds are a consequence of their chemical
and physical structures. Some BCPs have been classified as
osteoinductive due to their capacity tomodify gene expression
of human osteogenic and osteosarcoma cells and to
heterotopically induce bone formation, in in vivo models,
without the addition of bioactive molecules such as BMP
(bone morphogenetic protein), mostly in large animal models
(Rochet et al. 2003; Yuan et al. 2010; Barradas et al. 2011).
Recent studies have shed light on molecular mechanisms that
explain this intrinsic osteoinduction property which has been
attributed primarily to the chemical composition and physical
features, such as surface topography and size and shape of
pores of the biomaterial (Ripamonti 1996; LeGeros 2008;
Cheng et al. 2010; Yuan et al. 2010; Barradas et al. 2011;
Shih et al. 2014; Xia et al. 2014).
Nanostructured BCPs, composed of 65%HA/35 % ß-TCP
(Osteosynt®; EINCO Biomaterial, Belo Horizonte,
Minas Gerais, Brazil), which have interconnecting
micro- and macropores (diameters <10 and >100 μm, re-
spectively) (LeGeros et al. 2003; Lobo and Livingston
Arinzeh 2010) and various forms, have been successfully used
in orthopaedic and craniofacial applications (de Oliveira et al.
2007; Garrido et al. 2011; Fig. 1). However, their potential to
be used as scaffolds in combination with stem cells for tissue
engineering has not been investigated. Moreover, previous
clinical studies have shown that the reconstruction of segmen-
tal bone defects that exceed 3 cm in length in long bones using
these bioceramics may require more than one surgical proce-
dure or a longer period of time to heal (Garrido et al. 2011).
Thus, alternative therapeutic strategies are needed to recon-
struct these challenging defects. The combination of stem cells
with BCPs may be a viable approach.
Conversely, for bone tissue engineering applications, stem
cells isolated from different tissues have been associated with
a wide variety of biomaterials, including bioceramics, in order
to enhance bone tissue formation (Laranjeira et al. 2013;
Temple et al. 2014). Mesenchymal stem cells isolated from
bone marrow (MSCs), adipose-derived stem cells (ADSC)
and dental pulp stem cells (DPSC) are the most commonly
studied and characterized adult stem cell types (Shi et al. 2001;
Rosenbaum et al. 2008; Huang et al. 2009; Gronthos 2011;
Utsunomiya et al. 2011; Kerkis and Caplan 2012;
Harasymiak-Krzyzanowska et al. 2013). However, the litera-
ture is scarce on data that compares the response of different
stem cell types cultured on the same biomaterial.
This study was performed based on the hypotheses that: (1)
bioceramics presenting distinct chemical composition and
physical features elicit differential stem cell response and
may be osteoinductive, and that (2) stem cells isolated from
various tissues behave differently when seeded on the same
type of scaffold. This investigation aimed at analyzing the
potential of bioceramics, which have been successfully ap-
plied in orthopaedic and craniofacial surgeries (de Oliveira
et al. 2007; Garrido et al. 2011), to function as stem cell car-
riers and to induce their osteogenic differentiation, as well as
to compare the potential of bioceramics that present the same
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chemical composition and physical structure to trigger osteo-
genic fate of adult stem cells from different origins. Therefore,
the proliferation, viability and osteogenic differentiation of
MSCs cultured on six different BCP scaffolds, divided into
two groups, granules (G20-40, G40-60 and G60-80) and po-
rous blocks (BCP1, BCP2 and BCP3), were evaluated. The
granules had the same HA/TCP ratio but varied in physical
structure, i.e., granule size. The blocks differed in composi-
tion. Cell proliferation and viability were measured using two
different assays, DNA content and metabolic activity, over
time. The osteogenic differentiation was evaluated by gene
expression and alkaline phosphatase activity over time.
Moreover, the determination of osteogenic cell fate of MSC,
ADSC and DPSC on a granular form of BCP (G20-40) was
compared to pre-osteoblasts. Cell adhesion was analyzed
using scanning electron microscopy and the expression of




Nanostructured micro- and macroporous biphasic calcium
phosphate (BCP)-based bioceramics were provided by
EINCO Biomaterial in the form of granules and blocks. The
granules had different particle sizes and were irregular in
shape but had the same chemical composition: 65/35 (wt%/
wt%) HA/ß-TCP. They were named: G20-40 (corresponding
to granules of 20–40 mesh, with largest diameter of up to
1.5 mm); G40-60 (granules of 40–60 mesh, where the largest
diameter corresponded to 1 mm); and G60-80 (corresponding
to particles of 60–80mesh, which had an average of 0.7 mm at
the largest diameter). The blocks, 5 mm in diameter and 2 mm
in thickness, had different chemical compositions: BCP1 was
composed of 65/35 % HA/ß-TCP, i.e., the same composition
of the granules, BCP2 was a composite of HA and
poly(methyl 2-methylpropenoate), and BCP3 was composed
of 10 %/90 % HA/β-TCP ratio (Table 1). The chemical com-
position was verified by XRD (data not shown). The surface
topographies were assessed qualitatively by scanning electron









Bioceramics G20-40 65%/35% Granules *** ***
G40-60 65%/35% Granules *** **
G60-80 65%/35% Granules *** *
BCP1 65%/35% Blocks *** **
BCP2 100% HA/polymer Blocks *** ***
BCP3 10%/90% Blocks *** **
The BCPs were granules (G20-40, G40-60 and G60-80) and blocks
(BCP1, BCP2 and BCP3). Granules had the same microporosity
(<10 μm) but different particle sizes and macroporosity (>100 μm) (ob-
served by SEM). The granules and BCP1 had the same chemical compo-
sition but different physical features. Blocks had different compositions and
surface topographies. For porosity, a semi-quantitative grading system
varying from 3 to 1 asterisks was used for high to low porosity, respectively
Fig. 1 Reconstruction of tibial
defects caused by tumors (a–c)
and traumatic defects (d–f) using
granules of BCP corresponding to
20-40 mesh. Postoperative x-rays
of the tibia (a, b) and clinical as-
pect of the patient (c).
Preoperative image of the bone
defect (d) and its postoperative
analysis in the lateral (e) and
antero-posterior view (f)
(provided by Dr. W.N. da Silva)
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microscopy (SEM) viewing of the scaffolds’ surface. For the
comparative analysis of osteogenic differentiation of stem
cells from distinct origins, the granules G20-40 were used.
Cell culture
Human mesenchymal stem cells (MSCs) were isolated from
whole bone marrow from male donors, 18–30 years old
(Lonza, USA), as previously reported (Briggs et al. 2009),
and cultured in control media composed of Dulbecco’s
Modified Eagle’s Medium low glucose (Gibco; Invitrogen,
Carlsbad, CA, USA), supplemented with 10 % fetal bovine
serum (HyClone; Thermo Fisher Scientific, USA) and 100
units/ml antibiotic-antimycotic (Invitrogen). Adipose-derived
stem cells (ADSC; Poietics Human Adipose-Derived Stem
Cells) were purchased from Lonza (Walkersville, MD, USA)
and grown in ADSC Growth Medium (Bulletkit; Lonza).
Dental pulp stem cells (DPSC) were isolated from third mo-
lars extracted at the Department of Oral Surgery at New York
University College of Dentistry (reviewed and approved by
the Committee of Ethics), as previously reported (Kerkis et al.
2006). Briefly, after extraction, teeth were cleaned with
povidine, and odontosection was performed at the
cemento-enamel level using a low rotation saw under
profusion irrigation with saline solution. After exposure
of the pulp chamber, pulp tissue was removed from the
crown and roots, under sterile conditions, and placed in Petri
dishes with DMEM/F12 media (Gibco; Invitrogen) supple-
mented with 15 % FBS (HyClone®; Thermo Fisher
Scientific), 100 units/ml of penicillin/streptomycin (Sigma-
Aldrich, St. Louis, MO, USA), 2 mM L-glutamine (Gibco;
Invitrogen) and 2 mM non-essential amino acids (Gibco,
Invitrogen). The pulp was incubated at 37 °C, 5 % CO2, for
separation of stem cells from the extracellular matrix through
explant. Cells have been characterized elsewhere with regard
to their multipotency and cell membrane markers and shown
to be stem cells. Human pre-osteoblasts (MG-63; Lonza) were
cultured in Alpha-MEM (Minimum Essential MediumAlpha;
Gibco, Invitrogen), supplemented with 10 % FBS (HyClone;
Thermo Fisher Scientific) and 100 units/ml of penicillin/
streptomycin (Sigma-Aldrich).
Cells were expanded in control medium (basal medium)
until passage 3 and seeded onto the BCP scaffolds at
3 × 104cells/cm2 in polypropylene plates. Cells on scaffolds
were grown in control and osteogenic media (OS), comprised
of control media supplemented with 100 nM of dexametha-
sone, 0.05 mM of ascorbic acid and 10 mM of β-glycerophos-
phate. As control groups, cells were seeded directly on tissue
culture polystyrene plates (TCP) and cultured in both control
(C) and osteoinductive medium (OS), without scaffolds. In or-
der to avoid eventual influences on cell growth, viability, adhe-
sion and/or differentiation provided by the growth media, the
osteogenic media was used in the respective groups from the
time of cell seeding (i.e., control media was not initially applied
and later changed to OS media). Media was changed every 2–3
days and the cells were kept in a 5 % CO2 incubator at 37 °C.
Scanning electron microscopy
The physical features (presence of pores and surface topogra-
phies) of the BCPs as well as stem cells and pre-osteoblast
morphologies and adhesion to the scaffolds were observed
using SEM (Hitachi S-3500 N LV-SEM, Singapore). The con-
structs (stem cells on scaffolds) were washed twice with PBS
and fixed with Karnovsky solution (Karnovsky Fixative,
Electron Microscopy Sciences, Hatfield, PA, USA). The sam-
ples were then subjected to serial dehydration with 10, 30, 50,
70, 80, 90, and 100 % ethanol, dried overnight with 1,1,2-
triclorofluorethane and gold-coated. Bioceramics without
stem cells were directly coated with gold. Two samples of
each scaffold were analyzed and the constructs were evaluated
after 4 h, and 1, 7 and 14 days of culture.
Cell proliferation
Cell number was quantified using Quanti-iT PicoGreen
dsDNA Assay Kit (Molecular Probes, Invitrogen, USA).
Briefly, the cells were lysed using 0.1 % Triton X-100 for
30 min and incubated at room temperature for 5 min with
the fluorochrome PicoGreen, which stains the nucleic acid
by selective binding to the double-stranded DNA. The plates
were read on the spectrophotometer FLX800 microplate read-
er using KC Junior software at wavelength of 480 nm and
emission corresponding to 520 nm. Fours samples per group
per time point were studied; the assay was repeated twice and
the analysis was performed at days 4, 7, 11 and 14.
Cell viability
The cell viability was quantified using the XTT assay (XTT
Cell Viability Assay Kit; Biotium, Hayward, CA, USA),
which measures the activity of the mitochondrial enzymes,
according to the manufacturer’s protocol. The cell viability
was determined using a standard curve correlating absorbance
values to standards of known cell numbers. The absorbance
was measured with a spectrophotometer at wavelength of
450 nm. Four samples per group per time point were studied
and the assays were repeated twice. Samples were analyzed at
4, 11 and 14 days of culture.
qRT-PCR
The total RNA was isolated using Qiagen RNAeasy Kit
(Qiagen, CA, USA) and the DNA was excluded using
RNase Free DNase Set. Quantitative reverse transcriptase-
polymerase chain reaction (qRT-PCR) was performed using
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One Step QuantiTect SYBR Green RT-PCR Kit (Qiagen),
according to the manufacturer’s instructions. Specific oligo-
nucleotide primers for bone sialoprotein (integrin-binding
sialoprotein, IBSP; QT00093709); osteopontin (secreted
phosphoprotein 1, SPP; QT01008798); RUNX2 (runt-related
transcription factor 2; QT00020517); SOX9 (SRY [sex deter-
mining region Y]-box 9; QT00001498); PPARγ (peroxisome
proliferator-activated receptor; QT00029841); SOX2
(SRY-box 2; QT00237601) were analyzed and their rel-
ative gene expression was normalized to the relative expres-
sion of the housekeeping gene RPLP0 (ribosomal protein P0;
QT01839887) or GAPDH (glyceraldehyde-3-phosphate de-
hydrogenase; QT01192646). Samples were analyzed at days
1, 3, 7 and/or 14, assayed in triplicate for each time point, and
repeated twice. The reverse transcription was performed for
30 min at 50 °C, the PCR activation for 15 min at 95 °C, and
the amplification reactions were carried out through 40 cycles
(15 s denaturation at 94 °C, 30 s of annealing at 55 °C and 30 s
of extension at 72 °C) using the MX4000 detection system
(Stratagene, USA).
Alkaline phosphatase activity
The alkaline phosphatase activity was measured using the p-
Nitrophenyl phosphate assay (Sigma-Aldrich, USA) accord-
ing to the manufacturer’s protocol. The absorbance was mea-
sured at 405 nm using a spectrophotometer (Molecular
Devices, USA). Four samples per group per time point were
studied and the assay was repeated twice. Alkaline phospha-
tase activity was normalized to cell number, i.e., data from the
proliferation analysis (Quanti-iT PicoGreen dsDNA Assay).
The analyses were performed at days 7, 11 and 14.
Statistical analysis
Statistical analysis was performed using Bonferroni multiple-
significance test where comparisons for each one and between
the variables (time points, cell culture media, with and without
biomaterials and differences among biomaterials) were per-
formed (p < 0.05).
Results
All scaffolds had nanostructured surfaces with similar micro-
pores (<10 μm) as observed by SEM. The macropores
(>100 μm) as well as the surface topographies appeared to
vary among the six scaffolds. Macropores were ob-
served in all the scaffolds but to a lesser extent in the
G60-80 group. Among the blocks, the group BCP2 had
the most irregular surface and appeared to have more
macropores (Figs. 2 and 3). Cells were observed to adhere to
the surface of all the scaffolds and to penetrate their porous
Fig. 2 SEM images of the
granules with different particle
sizes (20–40 mesh, 40–60 mesh,
and 60–80 mesh). The shape and
size of the granules (a, a’, a^), the
size and presence of macropores
(b, b’, b^) and the micropores
(c, c’, c^) can be observed. Bars
(a, a’, a^) 1 mm, (b, b’, b^)
100 µm, (c, c’, c^) 10 µm
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Fig. 4 Morphological aspects of
stem cells and pre-osteoblasts on
tissue culture plate (a, a’, a^, a^’)
and on bioceramics G20-40 (b,
b’, b^, b^’ and c, c’, c^, c^’), in
control media, at day 7. Under
light microscopy, pre-osteoblasts
(MG-63) had round-shaped
morphology compared to stem
cells (a, a’, a^, a^’). When seeded
on the bioceramics, eventual
distinct morphological features of
the cells are not distinguishable
(b, b’, b^, b^’, c, c’, c^, c^’).
MSC mesenchymal stem cells,
ADSC adipose-derived stem cells,
DPSC dental pulp stem cells.
Scale bars (SEM) 50 μm
Fig. 3 SEM images of the blocks
(BCP1, BCP2 and BCP3)
showing distinct surface
topographies (a, a’, a^). Variation
in the size and amount of
macropores (b, b’, b^) were seen
whereas the presence of
micropores (c, c’, c^) were
observed in all of the scaffolds.
Bars (a, a’, a^) 1 mm, (b, b’, b^)
100 µm, (c, c’, c^) 10 µm
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structure. Stem cells from various tissues and pre-osteoblasts
had slightly different morphologies when cultured directly on
polystyrene plates (Fig. 4). Dental pulp stem cells were found
to extendmultiple filopodia-like protrusions within hours after
seeding which allowed them to adhere to the surfaces of the
bioceramics (Fig. 5). Thereafter, cells spread on the surface
and inside the pores of the BCP scaffolds (Fig. 4).
Cell number was higher on granules as compared to blocks
(Fig. 6). Almost all groups showed the highest cell number at
day 11 of culture. The cells cultured directly on polystyrene
plates showed higher number in osteogenic media as com-
pared to the control media (p < 0.05). However, cells cultured
on the BCPs did not show statistically significant differences
between both media (control and osteogenic). The group G60-
80 (granules with the smallest particle size, therefore present-
ing higher surface area for cell adhesion) in control media
showed the highest cell number at day 11 (p < 0.05)
(Fig. 6a). Among the blocks, cell number increased in the
group BCP2, although it was not statistically significant and
was lower than the control group in osteogenic media (MSC
OS) (Fig. 6b). Due to the fact that no significant differences in
cell proliferation were observed between days 7 and 11 and
that the latest (day 11) presented the highest cell number in
some experimental groups, day 7 was not included in further
assays. The groups G40-60 and BCP2 had the highest number
of viable cells amongst all bioceramic groups and G40-60 was
equivalent to the control group (Fig. 7).
The expression of bone sialoprotein (BSP) for cells grown
on TCP (tissue culture plate) and on granules in OS medium
increased over time (Fig. 8a). Interestingly, cells cultured on
BCP1 and BCP2 in control medium had an upregulation of
BSP as compared to OS medium at day 7. This increased
expression was also observed for granules 20–40 mesh
(G20-40) and 40–60 mesh (G40-60) at day 7 in control medi-
um as compared to OS medium (p<0.05). BSP expression
decreased on BCP3 group in both media over time (Fig. 8b).
High level of BSP was detected for the granules of 20–
40 mesh in control media at day 7 (Fig. 8).
The expression of osteopontin (OPN) was higher for cells
cultured on the bioceramics (granules and blocks) in both
media than on TCP (control groups, i.e., MSC C and MSC
OS) (Fig. 9). Exception was observed for cells on blocks
BCP3 OS at days 7 and 14 and BCP2 OS at day 14, which
had equivalent OPN gene expression compared to the group
MSC OS. Cells on granules G20-40 in control medium pre-
sented the highest OPN expression at day 7 amongst all
groups (Fig. 9a). Within the blocks, upregulation of OPN
was observed for cells grown on BCP1 (days 1, 7 and 14)
and BCP2 (day 7) in control medium as compared to OS
medium (Fig. 9b).
Due to the fact that the G20-40 group showed high
BSP and OPN gene expression in control medium, it
was used for the comparison of genes expressed at early
stages of differentiation by stem cells from different origins
as well as pre-osteoblasts. MSC, ADSC and DPSC had dis-
tinct profiles of mRNA expression for RUNX2, SOX9 and
PPARγ when cultured on TCP and in control (C) media
(Figs. 10a, 11a and 12a).
MSC C (control media) on TCP had predominant co-
expression of RUNX2 and SOX9 and very low levels of
PPARγ, at all time points (Fig. 10a). MSC OS (osteogenic
media) on TCP had increased expression of PPARγ over time,
with a peak on day 14. Furthermore, levels of RUNX-2 also
Fig. 5 Initial adhesion of a dental pulp stem cell, 4 h after seeding on
granules G20-40, mediated by the emission of filopodia-like structures.
Scale bars (a) 10 μm, (b-) 5 μm, (c) 1 μm
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increased from days 1 to 14, whereas SOX9 was concurrently
downregulated. SOX9 had the highest expression for MSC C
on TCP on day 14 (Fig. 10a). MSC C on BCP (G20-40)
significantly co-expressed RUNX2 and SOX9 throughout
the study, and very low levels of PPARγ were detected
(Fig. 10b). On day 7, SOX9 expression for MSC C on BCP
was higher than those for MSC C on TCP (p<0.05). The
levels of RUNX2 and SOX9 for MSC C on BCP on day 3
and of SOX9 on day 7, in the same conditions, were higher
than those for MSC OS on BCP (Fig. 10b). MSC OS on BCP
showed marked co-expression of RUNX2 and SOX9 on day
1, which was higher than that for all other groups at the same
time point. Conversely, levels of PPARγwere higher onMSC
OS on BCP in comparison to MSC C on BCP (Fig. 10b).
ADSC C on TCP expressed RUNX2 and SOX9 on days 1
and 3 when PPARγwas not detected. However, on days 7 and
14, the expression of PPARγ was significantly increased for
ADSC C (Fig. 11a). ADSC OS on TCP expressed PPARγ at
all time points, differently from ADSC C on TCP (Fig. 11).
These cells showed simultaneous upregulation of RUNX2
and SOX9 on day 1 in OS media but, at the later time points,
SOX9 was downregulated whereas the expressions of
RUNX2 and PPARγ remained high (Fig. 11b). ADSC C on
BCP showed simultaneous expression of RUNX2, SOX9, and
PPARγ at all time points, although on day 1, RUNX2 was
significantly upregulated (Fig. 11b). The levels of PPARγ
were lower for ADSC C on BCP compared to those of all
other groups; an exception was observed on day 1 for
Fig. 6 Mesenchymal stem cell
proliferation, evaluated by Pico-
Green assay, on granules (a) and
blocks (b). Higher cell number
was determined on granules as
compared to all the blocks.
Among the granules, the highest
cell number among all groups was
for the smallest particles
(60–80 mesh) in control media
(*p<0.05). Among the blocks,
higher cell number was
determined for BCP2 but was not
statistically significant. C control
media; OS osteogenic media
(*p<0.05). Values are mean± SE
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ADSC C on BCP, which expressed more PPARγ compared to
ADSC C on TCP. PPARγ was significantly downregulated
for ADSC C on BCP in comparison to ADSC C on TCP, on
days 3, 7, and 14. On the other hand, ADSC OS on BCP
showed increased expression of PPARγ compared to ADSC
C on BCP for all time points (Fig. 11b). These values
were, however, lower than those for ADSC OS on TCP.
The expression of RUNX2 and SOX9 were similar for
ADSC C on BCP and for ADSC OS on BCP. On day 1,
RUNX2 for ADSC C on BCP was higher than that for ADSC
OS on BCP, although this difference was not statistically sig-
nificant (Fig. 11).
On TCP, DPSC did not express PPARγ in C media, at any
time point but co-expressed RUNX2 and SOX9 (Fig. 12a).
Both DPSC C on TCP and DPSC OS on TCP expressed
mostly RUNX2 and SOX9 (Fig. 12a), except for DPSC OS
on TCP, in which case low levels of PPARγ were detected on
day 7 (Fig. 12a). The absence and very low levels of PPARγ
observed with DPSC is in contrast with the relatively very
high levels detected for ADSC. The highest gene expression
shown by DPSC was for RUNX2, at day 7, in OS media, on
TCP. DPSC C and DPSC OS, both on BCP, expressed
RUNX2 and SOX9 only (Fig. 12b). In addition, for DPSC
on BCP, in both C and OS media, the SOX9 expression was
higher than RUNX2 at all time points except on day 14, when
DPSC OS on BCP had equivalent values of RUNX2 and
SOX9 (Fig. 12b). DPSC C on BCP elicited higher SOX9
expression than DPSC OS on BCP on days 3, 7, and 14. On
Fig. 7 Mesenchymal stem cell
viability analyzed by XTT assay
showed that the granules (a), had
higher viable cells as compared to
the blocks (b) (p<0.05). The
BCP2 had the highest number of
viable cells among the blocks
(*p<0.05; ** p<0.01). Values are
mean± SE
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days 3 and 7, SOX9 was higher for DPSC C on BCP than for
DPSC OS on BCP (Fig. 12b).
Pre-osteoblasts (MG-63) in C and OS media, on TCP, re-
markably expressed SOX9 at all time points (Fig. 13a). On
day 1, the levels of RUNX2 and SOX9 forMG-63 OS on TCP
were equivalent but, at later time points, SOX9 was upregu-
lated, being significantly higher than RUNX2. No expression
of bone sialoprotein (BSP), a later osteogenic maker, was
detected for MG-63 on TCP, in both C and OS media
(Fig 13a). MG-63 C on BCP had increased expression of
RUNX2 on days 7 and 14 (Fig. 13b). On day 7, the expression
of SOX9 was higher for MG-63 C on BCP than for MG-63
OS on BCP (Fig. 13b). In OS media, MG-63 on BCP showed
increased co-expression of RUNX2 and SOX9 on day 14.
Pre-osteoblasts remarked expressed BSP (bone sialoprotein)
only when cultured on BCP, in both media, on day 14. Here,
BSP expression tended to be higher in C media compared to
that in OS media (Fig. 13b).
The alkaline phosphatase (ALP) activity of MSCs on poly-
styrene plate and on the six BCPs in OS media increased over
time and reached the highest values at day 14 (Fig. 14). MSC
seeded on bioceramics, granules and blocks, and on tissue cul-
ture polystyrene and grown in control media did not show ALP
activity (data not shown). Cells on BCP3 in OSmedium had the
lowest ALP activity and cells on BCP2 in OSmedium presented
the highest activity amongst all the groups at day 14 (Fig. 14b).
Fig. 8 Relative expression of
bone sialoprotein (BSP) for
mesenchymal stem cells on the
granules (a) and blocks (b), where
the values were normalized to the
housekeeping gene (RPLP0).
Cells cultured in OS media either
on tissue culture polystyrene or on
granules had increased BSP
expression from day 1 to day 14
(p< 0.05). Cells grown on
granules of 20–40mesh in control
media, at day 7, showed the
highest level of mRNA for BSP
amongst all groups, including
other granules and all blocks
(*p<0.05). Cells grown on
granules (20–40 mesh) and
blocks (BCP1 and BCP2) had
higher levels of mRNA for BSP
in control media in comparison to
OS media at day 7 (*p<0.05). At
day 14, statistical differences
were detected between BCP2 OS
and MSC OS (**p<0.05).
Among blocks, BCP2 at day 7 in
control media had the highest
expression of BSP (*p<0.05). OS
osteogenic media. Values are
mean± SE
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Discussion
This study compares the effect of six different biphasic calci-
um phosphate scaffolds, divided into two major groups, gran-
ules and blocks, on adhesion, viability, proliferation and oste-
ogenic differentiation of MSCs. It also compares the expres-
sion of early markers of osteogenic differentiation of stem
cells isolated from distinct sources cultured on a granular form
of BCP. Cells are grown in two different culture media, basal
(control) and osteoinductive.
Besides differing in physical form (granules of various
sizes versus blocks), the BCPs also differed in chemical
composition. Variations in both parameters (chemical and
physical) have been related to the creation of distinct
microenvironments, which can directly modulate cell re-
sponses as cells respond to both intrinsic and extrinsic (host
microenvironment) factors (Ohgushi and Caplan 1999;
Batouli et al. 2003; Rochet et al. 2003; Knothe Tate et al.
2008; Lee et al. 2013).
The biomaterials’ physical structures, including the fre-
quency, size and shape of the pores, are a result of the
manufacturing process and have been shown to play a role
in several stages of new bone formation, such as cell adhesion
and tissue ingrowth, after biomaterial implantation (Cheng
et al. 2010; Xia et al. 2014). Although porosity was not quan-
tified in this study, these materials contained pore structures at
both the micro- and macroscale. Increased porosity leads to
increased specific surface area, which also influences the
Fig. 9 Relative expression of
osteopontin (OPN) for
mesenchymal stem cells on
granules (a) and blocks (b)
(values were normalized to the
housekeeping gene RPLP0). The
mRNA levels were higher for
cells cultured on the granules for
all groups and time points
compared to the blocks
(*p<0.05). Cells cultured on both
G20-40 and G40-60 granules in
control medium had higher levels
of osteopontin expression as
compared to cells cultured on the
same biomaterials but in OS
medium at day 7 (*p<0.05). Cells
on G20–40 had higher expression
of osteopontin than all groups
(*p<0.05). Cells on BCP1 in
control medium at day 1 and
BCP2 in control medium at day 7
had the highest osteopontin
expression among blocks
(**p<0.05). Cells on BCP1 in OS
medium had higher osteopontin
expression as compared to MSCs
on tissue culture polystyrene in
OS medium at all time points
(**p<0.05). OS osteogenic
medium. Values are mean± SE
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scaffold solubilization (increased surface area favors solubili-
zation/bioresorption) (Cheng et al. 2010). On the other
hand, higher porosity generally lowers biomaterials’ me-
chanical properties regardless of their chemical compo-
sition (Lin et al. 2007). Specific surface area has also
been correlated to cell number: the higher the specific
surface area (which is the case of BCP surfaces com-
pared to the flat surfaces of tissue culture plates), the
higher the number of attached cells (O’Brien et al.
2005). Scaffolds’ solubilization/bioresorption are a func-
tion not only of physical structure but also of the scaffold’s
chemical composition and crystallinity. Amorphous biomate-
rials, such as tricalcium phosphates, favor solubilization over
the crystalline ones, such as hydroxyapatites (LeGeros 1993;
Lee et al. 2013).
Whereas macroporosity favors cell colonization and tissue
ingrowth, the microporosity has been related mostly to the
biomaterial’s capacity to adsorb biological fluids (including
the entrapment of proteins and other molecules—exogenous
or those presented in the site of surgical implantation)
(Ripamonti 1996; Cheng et al. 2010; Schumacher et al.
2010; Verron et al. 2010; Yuan et al. 2010). Such protein
adsorption, which is also a consequence of the biomaterials’
surface charge and wettability, has been considered the major
leading factor responsible for the intrinsic osteoinductivity
elicited by some but not all BCPs (Ripamonti 1996; Cheng
et al. 2010; Yuan et al. 2010). Considering that the BCP scaf-
folds analyzed here were rich in micropores, this may have
been a contributing factor for the upregulation of osteopontin
and bone sialoprotein, two late markers of osteogenic
Fig. 10 Gene expression profile
of mesenchymal stem cells
(MSC) seeded on tissue culture
plate (TCP) (a) and on biphasic
calcium phosphate bioceramics
(BCP) (b), in control and OS
media. Predominance of RUNX2
and SOX9 co-expression was
observed mainly in control media
in both surfaces (TCP and BCP),
as well as on BCP in OS medium,
indicating osteochondrogenic
differentiation. PPARγ was
upregulated when OS medium
was used. OS osteoinductive
medium (*p<0.05). Values were
normalized to the housekeeping
gene GAPDH. Values are
mean± SE
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differentiation, observed with cells grown in control me-
dia. The nanostructured surface may also have contrib-
uted to such response as already reported in the literature
(Li et al. 2012). These findings suggested that the BCPs may
be osteoinductive and not only osteoconductive materials.
Here, the influence of presentation form on cell response
was made evident mainly by the comparison of the granules
with the BCP1 block. Overall granules favored cell prolifera-
tion and differentiation over blocks. In control medium, larger
granules promoted cell differentiation, as observed by gene
expression analyses, compared to smaller ones. Moreover,
the presence of physical features, specifically micro- and
macropores of a biomaterial can substantially improve cell
viability, proliferation and differentiation as observed
with cells on BCP2 group. The importance of chemical
composition has been emphasized by the comparison of
BCP1 and BCP3 groups. Calcium phosphate bioceramics
have been shown to enrich the microenvironment through
calcium and phosphate ion release (Lin et al. 2007; Lee et al.
2013; Shih et al. 2014), otherwise provided by the calcium
levels in the media (Huang et al. 2007) and the addition of β-
glycerophosphate (a source of phosphate ions) in the osteo-
genic induction media (Beck et al. 2000). An optimal balance
of calcium and phosphate ions in the microenvironment
should exist in order to promote a favorable cell re-
sponse. However, there is evidence in the literature demon-
strating that the concentrations of the released ions from
calcium phosphate-based biomaterials—hydroxyapatite,
hydroxyapatite-collagen composite and calcium metaphos-
phate—do not interfere in adhesion and proliferation of
Fig. 11 Gene expression profile
of adipose derived stem cells
(ADSC) seeded on tissue culture
plate (TCP) (a) and on biphasic
calcium phosphate bioceramics
(BCP) (b), in both control and OS
media. Co-expression of RUNX2
and SOX9 was observed in all
experimental conditions.
However, significant
upregulation of PPARγ was
observed when cells were
cultured in OS media, mostly on
TCP, although its expression was
also detected in control media.OS
osteoinductive medium
(*p<0.05). Values were
normalized to the housekeeping
gene GAPDH. Values are
mean± SE
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adipose-derived stem cells and osteoblast-like cells (MC3T3)
(Lee et al. 2013). In spite of that, hydroxyapatites have elicited
greater expression of alkaline phosphatase m-RNA than
hydroxyapatite-collagen composite and calcium metaphos-
phate (Lee et al. 2013).
Cell proliferation and differentiation are highly coordinated
and inversely correlated processes: the more undifferentiated
the cells, the higher their proliferative potential (Zhu and
Skoultchi 2001). An increase in the number of cells cultured
in osteogenic media at day 11 may indicate an efficient MSC
proliferation prior to osteogenic differentiation, which oc-
curred at day 14. Such an event has been previously reported
and related to the proliferative stage that is part of the osteo-
genic differentiation (Huang et al. 2007). In our study, cells
cultured inOSmedia were lower in number compared to those
in control media.
In the present study, the alkaline phosphatase activity
remained low in the groups where cells were cultured in con-
trol media, with and without biomaterials. These data suggest
that the bioceramics may have induced the osteogenic differ-
entiation of MSCs (observed by the gene expression analyses)
but cells may not have progressed within the osteoblastic lin-
eage maturation. Although the ALP measurement has been
commonly used to demonstrate osteogenic differentiation,
this assay should not be considered conclusive (Weir and
Xu 2010).
However, for a biomaterial to be osteoinductive, it must
trigger (at early stages of differentiation) genes responsible
for directing stem cell fate. Osteoinduction, i.e., the commit-
ment of undifferentiated and/or immature cells toward the
osteoprogenitor cell lineage, represents the starting point of
the highly coordinated process of osteogenesis (Albrektsson
Fig. 12 Gene expression profile
of dental pulp stem cells (DPSC)
seeded on tissue culture plate
(TCP) (a) and on biphasic
calcium phosphate bioceramic
(BCP) (b), in both control and OS
media. Cells did not express
PPARγ, except in OS medium on
TCP (a). When cultured on BCP
in both media, DPSC showed
upregulation of SOX9 over
RUNX2 at all time points (b). OS
osteoinductive medium
(*p<0.05). Values were
normalized to the housekeeping
gene GAPDH. Values are
mean± SE
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and Johansson 2001; Baglio et al. 2013). In order to test the
osteoinductive capacity of the BCP, we investigated the ex-
pression of genes responsible for the determination of stem
cell fate, at early stages of differentiation (RUNX2, SOX9,
PPARγ), of multiple cell types. Therefore, stem cells isolated
from different sources (bone marrow, adipose tissue and den-
tal pulp) and pre-osteoblasts (MG-63) were cultured on the
BCP that showed the highest expression of BSP and OPN,
i.e., G20-40.
The levels and patterns of gene expression observed with
the stem cells cultured directly on TCP and in C media dem-
onstrated that they are inherently distinct. Variations in the
yield of cells, colony frequency, multipotency, proliferation
rate, immunomodulatory properties, cytokine secretion, mor-
phology, immunophenotype, transcriptome and proteome are
some of the differences that have been previously reported
(Shi et al. 2001; Kern et al. 2006; Bochev et al. 2008; Peng
et al. 2008; Rebelatto et al. 2008; Huang et al. 2009; Strioga
et al. 2012; Hu et al. 2013; Jin et al. 2013; Melief et al. 2013).
Mesenchymal fate and osteochondrogenesis, for endo-
chondral bone formation, are regulated by intricate pathways
where RUNX2 and SOX9 are the key transcription factors
(Zou et al. 2006; Grässel et al. 2009; Cheng and Genever
2010). Both are co-expressed by osteochondroprogenitor pre-
cursor cells that are found in the adult periosteum and endos-
teum and in fetal perichondrium, as well as in mandibular
secondary cartilages such as in the mandibular condyle and
Meckel’s cartilage (Leucht et al. 2008; Zhang et al. 2013).
RUNX2 (aka Osf2/Cbfa1, Pepb2α1 or AML3) is a critical
regulator of skeletal development, being observed in the
Fig. 13 Gene expression profile
of pre-osteoblasts (MG-63)
seeded on tissue culture plate
(TCP) (a) and on biphasic
calcium phosphate bioceramics
(BCP) (b), in both control and OS
media. Significant expression of
SOX9 was observed in all
experimental conditions. MG-63
expressed bone sialoprotein only
on BCP (b) but not on TCP (a).
On BCP, BSP levels were higher
in control as opposed to OSmedia
(b). RUNX2 was detected at later
time points (days 7 and 14) and
was upregulated on BCP as
compared to TCP. RUNX2
expression was higher on BCP
OS than on BCP control, on day
14. OS osteoinductive medium
(*p<0.05). Values were
normalized to the housekeeping
gene GAPDH. Values are
mean± SE
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mesenchymal condensations of the developing skeleton, and
is the master factor that controls osteoblastic differentiation
and chondrocyte maturation (Karsenty 1998; Lian et al.
2006; Zou et al. 2006; Komori 2010; Ding et al. 2012;
Nishimura et al. 2012). RUNX2 integrates signaling pathways
such as BMP/TGFbeta, Wnt, and Src (Lian et al. 2006), and
activates the promoters of several bone protein genes such as
COL1a1 (Komori 2010). On the other hand, SOX9 is known
to be a marker gene of chondrocytic phenotype besides
playing pivotal roles in the organogenesis of several organs
(Akiyama et al. 2002; Akiyama 2008; Nishimura et al. 2012;
Zhang et al. 2013). The co-expression of RUNX2 and SOX9
resembles the pattern of gene expression normally observed in
endochondral bone formation (Leucht et al. 2008; Cheng et al.
2010).
PPARγ is the master regulator of adipogenesis (Lee et al.
2013). Its suppression has been shown to increase the mRNA
levels of BMP2, RUNX2, osteocalcin and alkaline phospha-
tase of ADSC, thus enhancing its osteogenic differentiation
(Lee et al. 2013). The maintenance of PPARγ expression by
ADSC observed throughout this study suggests that long-term
analysis of in vivo bone formation should be performed to
verify the quality of the newly formed bone and its capacity
to reestablish the physiological turn-over of the bone tissue.
Conversely, ADSCs have been shown to be more promising
to reconstitute hematopoiesis of irradiated mice than MSCs
(Nakao et al. 2010).
DPSC expressed predominantly RUNX2 and SOX9.
However, it is important to note that odontoblast and osteo-
blast share potent regulators and are similar in terms of
immunophenotype and the expression of matrix proteins
(Nakashima et al. 1994; Gronthos et al. 2000). Nevertheless,
the application of DPSC for bone tissue engineering strategies
is questioned due to evidence that these cells generate a
dentin-like structure in vivo instead of lamellar bone as ob-
served with MSCs (Gronthos et al. 2000). On the other hand,
other authors have reported the formation of mature bone
using dental pulp stem cells isolated from deciduous teeth
instead of permanent teeth (de Mendonça Costa et al. 2008).
Bone sialoprotein (BSP) encodes a major bone matrix
structural phosphoprotein that presents an Arg-Gly-Asp
(RGD) cell-attachment sequence (Oldberg et al. 1988) and is
known to be involved in the nucleation of hydroxyapatite
during bone mineralization (Ogata 2008). The fact that pre-
osteoblasts expressed BSP only when cultured on BCP scaf-
folds suggests that these biomaterials may foster the progres-
sion of pre-osteoblast differentiation toward a more mature
cell phase than TCP. SOX2 is an important transcription factor
for the maintenance of the self-renewal capacity of embryonic
stem cells, among other functions (Avilion et al. 2003; Luo
et al. 2013). It was used as a negative control in this study.
SOX2was detected at very low levels for MSCs but not for all
other cell types.
The significance of this study relies on the demonstration
that bioceramics with either similar chemical composition, but
distinct physical features or vice versa, elicit diverse response
(proliferation vs. differentiation) of stem cells and that these,
when isolated from various tissues, differ in their gene expres-
sion profile at early stages of osteogenic differentiation when
in contact with the same type of scaffold (equal chemical and
physical structure). These data may be taken into account for
further tissue engineering strategies.
Conclusion
This study concluded that stem cells isolated from various
origins are inherently different and their behavior can be in-
fluenced by BCP scaffolds. Bioceramics, depending on their
chemical composition and physical features, may favor either
stem cell proliferation (small granules) or differentiation (large
granules). Blocks of bioceramics presenting rough surfaces
Fig. 14 Alkaline phosphatase (ALP) activity of mesenchymal stem cells
on the granules (a) and blocks (b), in osteogenic media. The production of
ALP increased over time, from day 1 to 14, for all the groups (*p<0.05).
Cells grown in control medium, with and without biomaterial, did not
show ALP activity (data not shown). All groups presented the highest
production of ALP at day 14. BCP2 at that time point (day 14) showed the
highest ALP activity among all groups (**p<0.05). MSC, G20-40 and
G40-60 were statistically equivalent but were higher than G60-80 at day
14 (*p<0.05). Values are mean± SE
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and a higher number of micro- and macroporosity favor cell
viability, proliferation and differentiation over biomaterials
with smooth surfaces and less porosity, even if their chemical
composition is considered less favorable for osteogenesis.
Long-term in vivo studies will be required to determine the
quality of newly formed bone promoted by stem cells from
different tissue sources.
Acknowledgments The authors pay tribute to the late Dr Racquel
LeGeros, in whose laboratory part of this study was performed; her
friendship, guidance and legacy will be remembered forever. This study
was supported by EINCO Biomaterial Ltda (Belo Horizonte, Minas
Gerais, Brazil) and CAPES (Coordenação de Aperfeiçoamento de
Pessoal de Nível Superior), Brazil.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
Akiyama H (2008) Control of chondrogenesis by the transcription factor
Sox9. Mod Rheumatol 18:213–219
Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B
(2002) The transcription factor Sox9 has essential roles in successive
steps of the chondrocyte differentiation pathway and is required for
expression of Sox5 and Sox6. Genes Dev 16:2813–2828
Albrektsson T, Johansson C (2001) Osteoinduction, osteoconduction and
osseointegration. Eur Spine J 10(Suppl 2):S96–S101
Arinzeh TL, Tran T, Mcalary J, Daculsi G (2005) A comparative study of
biphasic calcium phosphate ceramics for human mesenchymal
stem-cell-induced bone formation. Biomaterials 26:3631–3638
Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R
(2003) Multipotent cell lineages in early mouse development de-
pend on SOX2 function. Genes Dev 17:126–140
Baglio SR, Devescovi V, Granchi D, Baldini N (2013) MicroRNA ex-
pression profiling of human bone marrow mesenchymal stem cells
during osteogenic differentiation reveals Osterix regulation by miR-
31. Gene 527:321–331
Barradas AM, Yuan H, van Blitterswijk CA, Habibovic P (2011)
Osteoinductive biomaterials: current knowledge of properties, ex-
perimental models and biological mechanisms. Eur Cell Mater 21:
407–429
Batouli S, Miura M, Brahim J, Tsutsui TW, Fisher LW, Gronthos S,
Robey PG, Shi S (2003) Comparison of stem-cell-mediated osteo-
genesis and dentinogenesis. J Dent Res 82:976–981
Beck GR Jr, Zerler B, Moran E (2000) Phosphate is a specific signal for
induction of osteopontin gene expression. Proc Natl Acad Sci U S A
97:8352–8357
Bochev I, Elmadjian G, Kyurkchiev D, Tzvetanov L, Altankova I,
Tivchev P, Kyurkchiev S (2008) Mesenchymal stem cells from hu-
man bone marrow or adipose tissue differently modulate mitogen-
stimulated B-cell immunoglobulin production in vitro. Cell Biol Int
32:384–393
Briggs T, Treiser MD, Holmes PF, Kohn J, Moghe PV, Arinzeh TL
(2009) Osteogenic differentiation of humanmesenchymal stem cells
on poly(ethylene glycol)-variant biomaterials. J Biomed Mater Res
A 91:975–984
Cheng A, Genever PG (2010) SOX9 determines RUNX2 transactivity by
directing intracellular degradation. J BoneMiner Res 25:2680–2689
Cheng L, Ye F, Yang R, Lu X, Shi Y, Li L, Fan H, Bu H (2010)
Osteoinduction of hydroxyapatite/beta-tricalcium phosphate
bioceramics in mice with a fractured fibula. Acta Biomater 6:
1569–1574
de Mendonça Costa A, Bueno DF, Martins MT, Kerkis I, Kerkis A,
Fanganiello RD, Cerruti H, Alonso N, Passos-Bueno MR (2008)
Reconstruction of large cranial defects in nonimmunosuppressed
experimental design with human dental pulp stem cells. J
Craniofac Surg 19:204–210
de Oliveira RS, Brigado R, Madureira JF, Cruz AA, de Mello Filho FV,
Alonso N, Machado HR (2007) Reconstruction of a large complex
skull defect in a child: a case report and literature review. Childs
Nerv Syst 23:1097–1102
Ding M, Lu Y, Abbassi S, Li F, Song Y, Geoffroy V, Im HJ, Zheng Q
(2012) Targeting Runx2 expression in hypertrophic chondrocytes
impairs endochondral ossification during early skeletal develop-
ment. J Cell Physiol 227:3446–3456
Fellah BH, Delorme B, Sohier J, Magner D, Hardouin P, Layrolle P
(2010) Macrophage and osteoblast responses to biphasic calcium
phosphate microparticles. J Biomed Mater Res A 93:1588–1595
Garrido CA, Lobo SE, Turibio FM, LeGeros RZ (2011) Biphasic calcium
phosphate bioceramics for orthopaedic reconstructions: clinical out-
comes. Int J Biomater 2011:129727
Grässel S, Ahmed N, Göttl C, Grifka J (2009) Gene and protein expres-
sion profile of naive and osteo-chondrogenically differentiated rat
bone marrow-derived mesenchymal progenitor cells. Int J Mol Med
23:745–755
Gronthos S (2011) The therapeutic potential of dental pulp cells: more
than pulp fiction? Cytotherapy 13:1162–1163
Gronthos S, Mankani M, Brahim J, Robey PG, Shi S (2000) Postnatal
human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl
Acad Sci U S A 97:13625–13630
Harasymiak-Krzyzanowska I, Niedojadlo A, Karwat J, Kotula L, Gil-
Kulik P, Sawiuk M, Kocki J (2013) Adipose tissue-derived stem
cells show considerable promise for regenerative medicine applica-
tions. Cell Mol Biol Lett 18:479–493
Hu L, Hu J, Zhao J, Liu J, OuyangW, Yang C, Gong N, Du L, Khanal A,
Chen L (2013) Side-by-side comparison of the biological character-
istics of human umbilical cord and adipose tissue-derived mesen-
chymal stem cells. Biomed Res Int 2013:438243
Huang Z, Nelson ER, Smith RL, Goodman SB (2007) The sequential
expression profiles of growth factors from osteoprogenitors [correc-
tion of osteroprogenitors] to osteoblasts in vitro. Tissue Eng 13:
2311–2320
Huang GT, Gronthos S, Shi S (2009) Mesenchymal stem cells derived
from dental tissue vs. those from other sources: their biology and
role in regenerative medicine. J Dent Res 88:792–806
Jin HJ, Bae YK, KimM,Kwon SJ, JeonHB, Choi SJ, Kim SW,YangYS,
Oh W, Chang JW (2013) Comparative analysis of human mesen-
chymal stem cells from bone marrow, adipose tissue, and umbilical
cord blood as sources of cell therapy. Int J Mol Sci 14:17986–18001
Karsenty G (1998) Transcriptional regulation of osteoblast differentiation
during development. Front Biosci 3:d834–d837
Kerkis I, Caplan AI (2012) Stem cells in dental pulp of deciduous teeth.
Tissue Eng B 18:129–138
Kerkis I, Kerkis A, Dozortsev D, Stukart-Parsons GC, Gomes Massironi
SM, Pereira LV, Caplan AI, Cerruti HF (2006) Isolation and char-
acterization of a population of immature dental pulp stem cells ex-
pressing OCT-4 and other embryonic stem cell markers. Cells
Tissues Organs 184:105–116
Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative
analysis of mesenchymal stem cells from bone marrow, umbilical
cord blood, or adipose tissue. Stem Cells 24:1294–1301
Knothe Tate ML, Falls TD, McBride SH, Atit R, Knothe UR (2008)
Mechanical modulation of osteochondroprogenitor cell fate. Int J
Biochem Cell Biol 40:2720–2738
Cell Tissue Res (2015) 361:477–495 493
Komori T (2010) Regulation of bone development and extracellular ma-
trix protein genes by RUNX2. Cell Tissue Res 339:189–195
Laranjeira MS, Fernandes MH, Monteiro FJ (2013) Response of
monocultured and co-cultured human microvascular endothelial
cells and mesenchymal stem cells to macroporous granules of
nanostructured-hydroxyapatite agglomerates. J Biomed
Nanotechnol 9:1594–1606
Le Nihouannen D, Duval L, Lecomte A, Julien M, Guicheux J, Daculsi
G, Layrolle P (2007) Interactions of total bone marrow cells with
increasing quantities of macroporous calcium phosphate ceramic
granules. J Mater Sci Mater Med 18:1983–1990
Lee MJ, Chen HT, Ho ML, Chen CH, Chuang SC, Huang SC, Fu YC,
Wang GJ, Kang L, Chang JK (2013a) PPARγ silencing enhances
osteogenic differentiation of human adipose-derived mesenchymal
stem cells. J Cell Mol Med 17:1188–1193
Lee HR, Kim HJ, Ko JS, Choi YS, Ahn MW, Kim S, Do SH (2013b)
Comparative characteristics of porous bioceramics for an osteogenic
response in vitro and in vivo. PLoS ONE 8:e84272
LeGeros RZ (1993) Biodegradation and bioresorption of calcium phos-
phate ceramics. Clin Mater 14:65–88
LeGeros RZ (2008) Calcium phosphate-based osteoinductive materials.
Chem Rev 108:4742–4753
LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP (2003)
Biphasic calcium phosphate bioceramics: preparation, properties
and applications. J Mater Sci Mater Med 14:201–209
Leucht P, Minear S, Ten Berger D, Nusse R, Helms JA (2008) Translating
insights from development into regenerative medicine: the function
of Wnts in bone biology. Semin Cell Dev Biol 19:434–443
Li B, Liao X, Zheng L, Zhu X, Wang Z, Fan H, Zhang X (2012) Effect of
nanostructure on osteoinduction of porous biphasic calcium phos-
phate ceramics. Acta Biomater 8:3794–3804
Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M,
Hassan MQ, Gaur T, Lengner CJ, Young DW (2006) Networks
and hubs for the transcriptional control of osteoblastogenesis. Rev
Endocr Metab Disord 7:1–16
Lin Y, Wang T, Wu L, Jing W, Chen X, Li Z, Liu L, Tang W, Zheng X,
TianW (2007) Ectopic and in situ bone formation of adipose tissue-
derived stromal cells in biphasic calcium phosphate nanocomposite.
J Biomed Mater Res A 81:900–910
Livingston TL, Gordon S, Archambault M, Kadiyala S, Mcintosh K,
Smith A, Peter SJ (2003) Mesenchymal stem cells combined with
biphasic calcium phosphate ceramics promote bone regeneration. J
Mater Sci Mater Med 14:211–218
Lobo SE, Livingston Arinzeh T (2010) Biphasic calcium phosphate ce-
ramics for bone regeneration and tissue engineering applications.
Materials 3:815–826
LuoW, Li S, Peng B, Ye Y, Deng X, Yao K (2013) Embryonic stem cells
markers SOX2, OCT4 and Nanog expression and their correlations
with epithelial-mesenchymal transition in nasopharyngeal carcino-
ma. PLoS ONE 8:e56324
MarcacciM,Kon E,MoukhachevV, LavroukovA,Kutepov S, Quarto R,
Mastrogiacomo M, Cancedda R (2007) Stem cells associated with
macroporous bioceramics for long bone repair: 6- to 7- year out-
come of a pilot clinical study. Tissue Eng 13:947–955
Mastrogiacomo M, Scaglione S, Martinetti R, Dolcini L, Beltrame F,
Cancedda R, Quarto R (2006) Role of scaffold internal structure
on in vivo bone formation in macroporous calcium phosphate
bioceramics. Biomaterials 27:3230–3237
Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H,
Takakura Y, Ohgushi H (2009) In vivo osteogenic capability of
human mesenchymal cells cultured on hydroxyapatite and on beta-
tricalcium phosphate. Artif Organs 33:474–481
Melief SM, Zwaginga JJ, Fibbe WE, Roelofs H (2013) Adipose tissue-
derived multipotent stromal cells have a higher immunomodulatory
capacity than their bone marrow-derived counterparts. Stem Cells
Transl Med 2:455–463
Nakao N, Nakayama T, Yahata T, Muguruma Y, Saito S, Miyata Y,
Yamamoto K, Naoe T (2010) Adipose tissue-derived mesenchymal
stem cells facilitate hematopoiesis in vitro and in vivo: advantages
over bone marrow-derived mesenchymal stem cells. Am J Pathol
177:547–554
Nakashima M, Nagasawa H, Yamada Y, Reddi AH (1994) Regulatory
role of transforming growth factor-beta, bone morphogenetic pro-
tein-2, and protein-4 on gene expression of extracellular matrix pro-
teins and differentiation of dental pulp cells. Dev Biol 162:18–28
Nishimura R, Hata K, Matsubara T, Wakabayashi M, Yoneda T (2012)
Regulation of bone and cartilage development by network between
BMP signaling and transcription factors. J Biochem 151:247–254
O’Brien FJ, Harley BA, Yannas IV, Gibson LJ (2005) The effect of pore
size on cell adhesion in collagen – GAG scaffolds. Biomaterials 26:
433–441
Ogata Y (2008) Bone sialoprotein and its transcriptional regulatory mech-
anism. J Periodontal Res 43:127–135
Ohgushi H, Caplan AI (1999) Stem cell technology and bioceramics:
from cell to gene engineering. J Biomed Mater Res 48:913–927
Oldberg A, Franzén A, Heinegård D (1988) The primary structure of a
cell-binding bone sialoprotein. J Biol Chem 263:19430–19432
Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C (2008)
Comparative analysis of mesenchymal stem cells from bone mar-
row, cartilage and adipose tissue. Stem Cells Dev 17:761–773
Rebelatto CK, Aguiar AM, Moretão MP, Senegaglia AC, Hansen P,
Barchiki F, Oliveira J, Martins J, Kuligovski C, Mansur F,
Christofis A, Amaral VF, Brofman PS, Goldenberg S, Nakao LS,
Correa A (2008) Dissimilar differentiation of mesenchymal stem
cells from bone marrow, umbilical cord blood, and adipose tissue.
Exp Biol Med (Maywood) 233:901–913
Ripamonti U (1996) Osteoinduction in porous hydroxyapatite implanted
in heterotopic sites of different animal models. Biomaterials
17:31–35
Rochet N, Loubat A, Laugier JP, Hofman P, Bouler JM, Daculsi G, Carle
GF, Rossi B (2003) Modification of gene expression induced in
human osteogenic and osteosarcoma cells by culture on a biphasic
calcium phosphate bone substitute. Bone 32:602–610
Rosenbaum AJ, Grande DA, Dines JS (2008) The use of mesenchymal
stem cells in tissue engineering: a global assessment. Organogenesis
4:23–27
Saldaña L, Sánchez-Salcedo S, Izquierdo-Barba I, Bensiamar F, Munuera
L, Vallet-Regi M, Vilaboa N (2009) Calcium phosphate-based par-
ticles influence osteogenic maturation of human mesenchymal stem
cells. Acta Biomater 5:1294–1305
Schumacher M, Deisinger U, Detsch R, Ziegler G (2010) Indirect rapid
prototyping of biphasic calcium phosphate scaffolds as bone substi-
tutes: influence of phase composition, macroporosity and pore
geometry on mechanical properties. J Mater Sci Mater Med
21:3119–3127
Shi S, Robey PG, Gronthos S (2001) Comparison of human dental pulp
and bone morrow stromal stem cells by cDNA microarray analysis.
Bone 29:532–539
Shih YR, Hwang Y, Phadke A, Kang H, Hwang NS, Caro EJ, Nguyen S,
Siu M, Theodorakis EA, Gianneschi NC, Vecchio KS, Chien S, Lee
OK, Varghese S (2014) Proc Natl Acad Sci U S A 111:990–995
Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J (2012)
Same or not the same? comparison of adipose tissue-derived versus
bone marrow-derived mesenchymal stem and stromal cells. Stem
Cells Dev 21:2724–2752
Teixeira S, Fernandes H, Leusink A, van Blitterswijk C, Ferraz MP,
Monteiro FJ, de Boer J (2010) In vivo evaluation of highly
macroporous ceramic scaffolds for bone tissue engineering. J
Biomed Mater Res A 93:567–575
Temple JP, Hutton DL, Hung BP, Huri PY, Cook CA, Kondragunta R, Jia
X, Grayson WL (2014) Engineering anatomically shaped
494 Cell Tissue Res (2015) 361:477–495
vascularized bone grafts with hASC and 3D-printed PCL scaffolds.
J Biomed Mater Res A. doi:10.1002/jbm.a.35107
Utsunomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori H,
Hanaoka J, Iwahashi S, Saito Y, Iwaguro H (2011) Human
adipose-derived stem cells: potential clinical applications in surgery.
Surg Today 41:18–23
Verron E, Khairoun I, Guicheux J, Bouler JM (2010) Calcium phosphate
biomaterials as bone drug delivery systems: a review. Drug Discov
Today 15:547–552
Wang L, Fan H, Zhang ZY, Lou AJ, Pei GX, Jiang S, Mu TW, Qin JJ,
Chen SY, Jin D (2010) Osteogenesis and angiogenesis of
tissue-engineered bone constructed by prevascularized β-
tricalcium phosphate scaffold and mesenchymal stem cells.
Biomaterials 31:9452–9461
Weir MD, Xu HH (2010) Osteoblastic induction on calcium phosphate
cement-chitosan constructs for bone tissue engineering. J Biomed
Mater Res A 94:223–233
Xia L, Lin K, Jiang X, Fang B, Xu Y, Liu J, Zeng D, ZhangM, Zhang X,
Chang J, Zhang Z (2014) Effect of nano-structured bioceramic sur-
face on osteogenic differentiation of adipose derived stem cells.
Biomaterials 35:8514–8527
Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de Ruiter A,
Walsh WR, van Blitterswijk CA, de Bruijn JD (2010)
Osteoinductive ceramics as a synthetic alternative to autologous
bone grafting. Proc Natl Acad Sci U S A 107:13614–13619
Zhang H, Zhao X, Zhang Z, Chen W, Zhang X (2013) An immunohis-
tochemical study of Sox9, Runx2, and Osterix expression in the
mandibular cartilages of newborn mouse. Biomed Res Int 2013:
265380
Zhu L, Skoultchi AI (2001) Coordinating cell proliferation and differen-
tiation. Curr Opin Genet Dev 11:91–97
Zou L, Zou X, Li H, Mygind T, Zeng Y, Lü N, Bünger C (2006)
Molecular mechanism of osteochondroprogenitor fate determination
during bone formation. Adv Exp Med Biol 585:431–441
Cell Tissue Res (2015) 361:477–495 495
